Anand Rathi is bullish on Dhanuka Agritech has recommended buy rating on the stock with a target price of Rs 1900 in its research report dated August 04, 2025.
The market is expected to continue rangebound trading until the index decisively surpasses and sustains above the high of the month of May. Below are some short-term trading ideas to consider.
Anand Rathi is bullish on Dhanuka Agritech has recommended buy rating on the stock with a target price of Rs 1850 in its research report dated February 10, 2025.
HSBC stated that good rainfall will enhance water storage, boosting domestic sales for agri-input players in H2 FY25. As a result, the firm anticipates a strong overall performance from the sector in FY25.
The two companies will also explore setting up a Research & Development facility in the country, Dhanuka Agritech said in a statement.
Dhanuka Agritech Limited is one of India’s leading agri-input company and is listed by Forbes Magazine in the category of “200 Best under A Billion Companies in Asia Pacific”. It has three state of art manufacturing facilities in Rajasthan, Gujarat and J&K with well-equipped Quality Testing Facilities. The company has developed in–house expertise in the field of registration of new molecules in India and data generation.
Orchid Pharma's Promoter Dhanuka Laboratories sold 13 lakh equity shares or a 2.56 percent stake, in the company via open market transaction at an average price of Rs 571.28 per share.
Dhanuka Agritech Limited is one of India’s leading agri-input companies and was among the Forbes magazine's “200 Best under A Billion Companies in Asia Pacific”. It has three state-of-the-art manufacturing facilities in Rajasthan, Gujarat and J&K with well-equipped quality testing facilities. The company has developed in–house expertise in registering new molecules in India as well as data generation
Prabhudas Lilladher is bullish on Dhanuka Agritech has recommended buy rating on the stock with a target price of Rs 950 in its research report dated August 02, 2023.